Risk Factors for Tigecycline-Associated Hypofibrinogenemia
Jia Liu,1 Yingying Yan,2 Fan Zhang1 1Department of Geriatrics, Peking University Third Hospital, Beijing, People’s Republic of China; 2Department of Pharmacy, Peking University Third Hospital, Beijing, People’s Republic of ChinaCorrespondence: Fan ZhangDepartment of Geriatrics, P...
Guardado en:
Autores principales: | Liu J, Yan Y, Zhang F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29de2747630c4bdd91dee82307a72f01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management
por: Tomas Simurda, et al.
Publicado: (2021) -
Tigecycline activity against metallo-β-lactamase-producing bacteria
por: Simit Kumar, et al.
Publicado: (2013) -
Coagulation Disorders in COVID-19: Role of Toll-like Receptors
por: Biswas I, et al.
Publicado: (2020) -
Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Anna Giammanco, et al.
Publicado: (2017) -
The Prevalence and Risk Factors of Cerebral Microbleeds: A Community-Based Study in China
por: Luo Q, et al.
Publicado: (2021)